0,866  0,004  GST A substrate
0,849  0,005  Caspase 9 stimulant
0,831  0,004  Sensitization
0,745  0,005  CTGF expression inhibitor
0,706  0,005  Antimutagenic
0,694  0,005  Free radical scavenger
0,687  0,005  Amyloid beta aggregation inhibitor
0,688  0,011  Chemoprotective
0,681  0,006  Antioxidant
0,671  0,004  Sulfotransferase substrate
0,686  0,022  Transcription factor NF kappa B inhibitor
0,673  0,016  TNF expression inhibitor
0,677  0,023  Antineoplastic (breast cancer)
0,664  0,011  Cholesterol antagonist
0,650  0,003  Cystathionine beta-synthase inhibitor
0,675  0,035  Apoptosis agonist
0,636  0,008  Lipoxygenase inhibitor
0,632  0,012  Vasodilator, peripheral
0,621  0,007  Ulceration
0,619  0,005  Antihypoxic
0,627  0,013  Radioprotector
0,604  0,005  Skin whitener
0,594  0,007  Superoxide dismutase inhibitor
0,598  0,011  Antipruritic, allergic
0,587  0,003  GST P1-1 substrate
0,588  0,005  Monophenol monooxygenase inhibitor
0,583  0,011  NOS2 expression inhibitor
0,580  0,009  Skin irritative effect
0,566  0,005  Melanin inhibitor
0,575  0,019  Antihypercholesterolemic
0,605  0,052  Antiinflammatory
0,584  0,032  Antineoplastic (lung cancer)
0,550  0,007  Antihypertriglyceridemic
0,545  0,003  Carbonic anhydrase VI inhibitor
0,555  0,014  Apoptosis antagonist
0,555  0,017  Antineoplastic (cervical cancer)
0,562  0,029  Antileukemic
0,526  0,012  Eye irritation, high
0,535  0,028  Aldehyde oxidase inhibitor
0,520  0,018  Chemopreventive
0,518  0,019  Mutagenic
0,509  0,012  UGT1A6 substrate
0,499  0,005  VCAM1 expression inhibitor
0,499  0,006  Phospholipase C inhibitor
0,512  0,019  AR expression inhibitor
0,495  0,012  UGT2B4 substrate
0,483  0,005  Pneumotoxic
0,479  0,005  GST M1-1 substrate
0,475  0,003  Carbonic anhydrase XIII inhibitor
0,478  0,008  Antiseptic
0,484  0,016  Antipyretic
0,487  0,021  UGT1A9 substrate
0,484  0,020  Proliferative diseases treatment
0,471  0,008  Carcinogenic, group 3
0,498  0,036  CYP2C9 substrate
0,467  0,007  Amylase inhibitor
0,464  0,005  Protein kinase stimulant
0,492  0,034  Prostate cancer treatment
0,488  0,032  Calcium channel L-type activator
0,464  0,009  UGT1A3 substrate
0,461  0,007  Platelet adhesion inhibitor
0,481  0,031  GABA C receptor rho-3 antagonist
0,466  0,019  Antiamyloidogenic
0,475  0,031  CYP2C19 inhibitor
0,466  0,026  Carcinogenic
0,484  0,044  15-Lipoxygenase inhibitor
0,460  0,021  Vasodilator, coronary
0,450  0,011  Transcription factor STAT3 inhibitor
0,463  0,026  Caspase 3 stimulant
0,468  0,036  Teratogen
0,435  0,004  Carbonic anhydrase III inhibitor
0,439  0,012  Anesthetic general
0,450  0,023  ICAM1 expression inhibitor
0,460  0,036  Antithrombotic
0,465  0,043  Histamine release inhibitor
0,455  0,034  CYP2C19 substrate
0,449  0,028  NOS3 expression inhibitor
0,441  0,021  Nitric oxide antagonist
0,433  0,014  Transcription factor STAT inhibitor
0,424  0,007  NOS3 expression enhancer
0,431  0,014  UGT1A1 substrate
0,428  0,012  Abortion inducer
0,439  0,024  Antiprotozoal (Leishmania)
0,417  0,004  HIV-1 integrase (3'-Processing) inhibitor
0,449  0,036  Embryotoxic
0,432  0,027  Antineoplastic (non-small cell lung cancer)
0,423  0,017  Peroxidase inhibitor
0,411  0,007  Antidote
0,406  0,004  Antihelmintic (Nematodes)
0,424  0,023  DNA damaging
0,421  0,024  Hypoglycemic
0,400  0,004  Histidine decarboxylase inhibitor
0,412  0,019  UDP-glucuronosyltransferase substrate
0,420  0,027  Cardiovascular analeptic
0,395  0,005  5-Lipoxygenase inhibitor
0,398  0,008  Tyrosine 3 hydroxylase inhibitor
0,407  0,022  Calcium channel activator
0,402  0,022  Insulysin inhibitor
0,404  0,024  Antiparasitic
0,420  0,041  Respiratory analeptic
0,399  0,020  Antiulcerative
0,388  0,011  Genotoxic
0,414  0,037  Antineoplastic (melanoma)
0,422  0,049  Antineoplastic (colorectal cancer)
0,413  0,041  FMO1 substrate
0,371  0,004  HIV-1 integrase (Strand Transfer) inhibitor
0,400  0,039  Lipoprotein disorders treatment
0,398  0,038  Cardioprotectant
0,383  0,023  Antineoplastic (endocrine cancer)
0,376  0,019  P-glycoprotein inhibitor
0,374  0,019  Antihelmintic
0,378  0,025  Sigma receptor agonist
0,385  0,032  Radiosensitizer
0,401  0,050  Antineoplastic (colon cancer)
0,396  0,045  Antineoplastic (ovarian cancer)
0,375  0,026  Pyruvate kinase inhibitor
0,350  0,005  Succinate dehydrogenase inhibitor
0,357  0,015  Antipruritic, non-allergic
0,351  0,009  Insulin sensitizer
0,345  0,005  Xanthine oxidase inhibitor
0,383  0,046  Antipsoriatic
0,340  0,003  Heat shock protein 70 antagonist
0,366  0,029  FMO3 substrate
0,380  0,045  12-Lipoxygenase inhibitor
0,364  0,030  Vasodilator
0,371  0,038  CYP1A2 inhibitor
0,348  0,015  MAO inhibitor
0,376  0,044  Analeptic
0,406  0,074  5 Hydroxytryptamine release inhibitor
0,333  0,005  Choleretic
0,360  0,033  Antineoplastic (osteosarcoma)
0,426  0,104  Alpha-glucosidase inhibitor
0,336  0,014  Lipid peroxidase inhibitor
0,334  0,015  Interferon gamma antagonist
0,355  0,037  Platelet antagonist
0,374  0,057  Bone diseases treatment
0,359  0,042  Hypoxia-inducible factor 1 alpha inhibitor
0,327  0,010  Glutathione S-transferase substrate
0,319  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,368  0,055  Antifungal
0,318  0,005  Phobic disorders treatment
0,346  0,034  Vascular (periferal) disease treatment
0,392  0,080  Antibacterial
0,324  0,014  UGT2B15 substrate
0,356  0,048  Antiosteoporotic
0,324  0,016  Acaricide
0,346  0,039  Tumour necrosis factor alpha release inhibitor
0,310  0,003  Carbonic anhydrase XIV inhibitor
0,342  0,038  Antineoplastic (renal cancer)
0,359  0,056  Hepatic disorders treatment
0,315  0,014  Amyloid beta precursor protein antagonist
0,337  0,039  Antidiabetic symptomatic
0,307  0,009  Carcinogenic, group 2B
0,350  0,052  Antineoplastic (brain cancer)
0,302  0,007  Mediator release inhibitor
0,329  0,035  DNA synthesis inhibitor
0,315  0,021  DNA methyltransferase I inhibitor
0,297  0,004  Keratolytic
0,365  0,073  CYP2C9 inhibitor
0,344  0,053  CYP1A2 substrate
0,331  0,040  Hypolipemic
0,324  0,036  Antineoplastic (lymphocytic leukemia)
0,327  0,041  Antineoplastic (liver cancer)
0,312  0,026  Hepatoprotectant
0,295  0,010  SULT1A3 substrate
0,327  0,042  Interleukin antagonist
0,290  0,006  Estrogen antagonist
0,296  0,013  M18 aspartyl aminopeptidase inhibitor
0,295  0,012  Cholesterol synthesis inhibitor
0,293  0,011  Chelator
0,290  0,011  Carcinogenic, group 1
0,297  0,019  Protein-tyrosine phosphatase inhibitor
0,284  0,007  Antieczematic
0,303  0,029  Antihypotensive
0,317  0,043  Angiogenesis stimulant
0,283  0,009  Uterine stimulant
0,300  0,028  DNA methylase inhibitor
0,280  0,010  Expectorant
0,322  0,053  Antineoplastic (multiple myeloma)
0,320  0,052  Antineoplastic (glioma)
0,294  0,028  UGT2B7 substrate
0,278  0,013  Antifungal enhancer
0,280  0,017  MAO A inhibitor
0,268  0,005  Macrophage migration inhibitory factor inhibitor
0,327  0,068  CYP2D6 substrate
0,305  0,047  Antiglaucomic
0,300  0,045  5 Hydroxytryptamine uptake stimulant
0,337  0,083  CYP3A4 substrate
0,265  0,011  Interleukin 1b antagonist
0,268  0,015  Aldehyde dehydrogenase inhibitor
0,267  0,016  Interleukin 1 antagonist
0,254  0,004  Carbonic anhydrase V inhibitor
0,253  0,004  Carbonic anhydrase VB inhibitor
0,275  0,026  CYP2B6 inhibitor
0,273  0,024  Tumour necrosis factor antagonist
0,273  0,025  Anesthetic
0,252  0,004  Toll-Like receptor 4 antagonist
0,256  0,008  Beta glucuronidase inhibitor
0,313  0,066  5 Hydroxytryptamine release stimulant
0,267  0,020  Alpha-N-acetylglucosaminidase inhibitor
0,261  0,016  MAO B inhibitor
0,253  0,009  Toll-Like receptor 2 antagonist
0,295  0,052  Myocardial infarction treatment
0,322  0,080  Antiallergic
0,293  0,052  Cytotoxic
0,261  0,021  Phospholipase A2 inhibitor
0,272  0,035  Non-steroidal antiinflammatory agent
0,239  0,006  Vanilloid 1 agonist
0,247  0,014  Interleukin 4 antagonist
0,257  0,024  Tubulin antagonist
0,237  0,006  Gastritis treatment
0,299  0,070  Spasmolytic
0,232  0,004  GABA aminotransferase inhibitor
0,238  0,011  Antirickettsial
0,238  0,011  SULT1A1 substrate
0,236  0,010  Antispirochetal
0,241  0,016  ATPase inhibitor
0,229  0,004  Ornithine decarboxylase inhibitor
0,240  0,016  UGT2B10 substrate
0,240  0,018  Protein-tyrosine phosphatase 1B inhibitor
0,244  0,022  Cyclooxygenase 1 inhibitor
0,323  0,101  Immunosuppressant
0,275  0,055  Antineoplastic (glioblastoma multiforme)
0,264  0,044  Neuropeptide Y2 antagonist
0,299  0,080  Sodium/bile acid cotransporter inhibitor
0,224  0,004  Glutathione S-transferase inhibitor
0,239  0,020  Antiprotozoal (Coccidial)
0,223  0,005  DOPA decarboxylase inhibitor
0,221  0,004  Carbonic anhydrase VA inhibitor
0,226  0,011  Catalase inhibitor
0,234  0,021  VEGF expression inhibitor
0,228  0,016  GABA C receptor agonist
0,218  0,006  Alcohol oxidase inhibitor
0,276  0,067  Flavin-containing monooxygenase substrate
0,227  0,018  GABA C receptor rho-2 antagonist
0,284  0,075  Antineoplastic (pancreatic cancer)
0,220  0,011  Dementia treatment
0,215  0,011  Vascular dementia treatment
0,212  0,009  TRPA1 agonist
0,305  0,102  Stroke treatment
0,220  0,017  Arachidonic acid antagonist
0,234  0,033  Antiacne
0,240  0,040  Nitric-oxide synthase stimulant
0,208  0,008  Prolactin inhibitor
0,242  0,043  UGT1A4 substrate
0,261  0,063  5 Hydroxytryptamine 1E antagonist
0,260  0,063  Antineoplastic (lymphoma)
0,210  0,013  Breast cancer-resistant protein inhibitor
0,231  0,034  Restenosis treatment
0,224  0,030  Corneal wound healing stimulator
0,221  0,027  Neurotensin receptor agonist
0,279  0,086  Antiischemic
0,221  0,030  UGT2B9 substrate
0,203  0,012  Adenylate cyclase stimulant
0,215  0,024  DNA polymerase I inhibitor
0,277  0,086  Immunostimulant
0,198  0,009  Thioredoxin inhibitor
0,194  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,200  0,010  Antiviral (Influenza B)
0,260  0,071  Interleukin agonist
0,206  0,018  Carbonic anhydrase XV inhibitor
0,283  0,099  Antineoplastic (small cell lung cancer)
0,188  0,005  Carbonic anhydrase VII inhibitor
0,196  0,014  Photosensitizer
0,249  0,068  Cardiodepressant
0,243  0,062  Antimitotic
0,197  0,016  UGT2B1 substrate
0,187  0,007  Prostaglandin EP2 antagonist
0,239  0,060  Antineoplastic enhancer
0,182  0,005  HIV-1 integrase inhibitor
0,235  0,060  RNA-directed DNA polymerase inhibitor
0,230  0,056  Antiviral (Influenza)
0,195  0,021  Microtubule formation inhibitor
0,188  0,015  Calcium antagonist
0,226  0,054  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,209  0,039  Cyclooxygenase inhibitor
0,212  0,045  LDLR expression enhancer
0,180  0,013  Actinic keratosis treatment
0,194  0,028  Gout treatment
0,208  0,042  Hair growth stimulant
0,231  0,066  Peptidyltransferase inhibitor
0,174  0,009  Aldose reductase inhibitor
0,187  0,022  Antihelmintic (Trematoda)
0,205  0,040  Antineoplastic (squamous cell carcinoma)
0,182  0,018  Mucolytic
0,169  0,005  Xanthine dehydrogenase inhibitor
0,180  0,018  Aldehyde dehydrogenase substrate
0,174  0,012  Estrogen receptor beta antagonist
0,171  0,012  Ca2+-transporting ATPase inhibitor
0,185  0,026  Antibacterial (Helicobacter pylori)
0,187  0,028  Cell adhesion inhibitor
0,167  0,009  UGT2B11 substrate
0,273  0,116  Prostaglandin dehydrogenase inhibitor
0,310  0,154  Antidiabetic
0,310  0,154  Cyclophilin D inhibitor
0,164  0,009  Antiviral (Rhinovirus)
0,164  0,009  Leukotriene antagonist
0,184  0,029  Adenylate cyclase inhibitor
0,158  0,004  Estrogen-related receptor beta agonist
0,273  0,119  Thioredoxin glutathione reductase inhibitor
0,172  0,019  Antihelmintic (Fasciola)
0,215  0,063  Neurotrophic factor enhancer
0,155  0,005  Estradiol 17 beta-dehydrogenase inhibitor
0,157  0,007  NMDA receptor agonist
0,302  0,153  Transcription factor inhibitor
0,185  0,036  Cocaine dependence treatment
0,172  0,024  Alcohol dehydrogenase substrate
0,153  0,005  SULT1A2 substrate
0,231  0,084  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,224  0,078  Cyclic AMP phosphodiesterase inhibitor
0,164  0,019  Creatine kinase inhibitor
0,164  0,020  Caspase 3 inhibitor
0,157  0,013  SULT1E1 substrate
0,148  0,005  Granulocyte macrophage colony stimulating factor agonist
0,151  0,012  Phenylalanine 4-hydroxylase inhibitor
0,156  0,016  Antifungal (Pneumocystis)
0,189  0,049  Antiviral (Influenza A)
0,193  0,054  Heat shock protein 90 alpha antagonist
0,178  0,039  Toll-Like receptor antagonist
0,159  0,022  HIV-1 integrase (Overall Integration) inhibitor
0,195  0,058  Muscle relaxant
0,141  0,005  NMDA receptor glycine site agonist
0,178  0,044  Mannose-6-phosphate isomerase inhibitor
0,158  0,025  Falcipain 2 inhibitor
0,168  0,035  Cyclooxygenase 3 inhibitor
0,160  0,027  Falcipain inhibitor
0,181  0,048  Heat shock protein 90 antagonist
0,149  0,017  Acetylcholine release stimulant
0,139  0,007  Anticholelithogenic
0,157  0,028  Papain-like protease (SARS coronavirus) inhibitor
0,170  0,041  Anesthetic local
0,148  0,021  Porphobilinogen synthase inhibitor
0,141  0,015  Glutamate decarboxylase inhibitor
0,139  0,014  Interleukin 5 antagonist
0,148  0,024  Uric acid excretion stimulant
0,132  0,009  Narcotic antagonist
0,190  0,068  Antiviral (Hepatitis)
0,128  0,007  Endocannabinoid uptake inhibitor
0,269  0,148  Antiprotozoal
0,124  0,004  Glucose-6-phosphate translocase inhibitor
0,128  0,009  Maillard reaction inhibitor
0,144  0,024  GABA C receptor rho-1 antagonist
0,131  0,013  Estrogen agonist
0,147  0,028  Gastric antisecretory
0,127  0,009  Protease 3C (Human rhinovirus) inhibitor
0,131  0,013  Thioredoxin reductase inhibitor
0,157  0,039  Antiprotozoal (Amoeba)
0,175  0,059  Catenin beta inhibitor
0,122  0,007  Leukotriene B4 antagonist
0,171  0,057  Hexokinase inhibitor
0,146  0,032  GABA C receptor antagonist
0,129  0,016  Estrogen receptor alpha antagonist
0,126  0,014  Leukotriene synthesis inhibitor
0,154  0,043  Cathepsin H inhibitor
0,137  0,026  Carcinogenic, group 2A
0,173  0,062  Antiviral (Hepatitis C)
0,202  0,091  Antiviral (HIV)
0,177  0,068  Liver fibrosis treatment
0,135  0,027  Anabolic
0,204  0,096  Cytostatic
0,149  0,041  Coagulant
0,138  0,032  Adenylate kinase inhibitor
0,162  0,056  Skeletal muscle relaxant
0,155  0,050  Cyclooxygenase 2 inhibitor
0,175  0,070  Mcl-1 antagonist
0,152  0,048  Antihyperlipoproteinemic
0,121  0,018  Vanilloid agonist
0,150  0,047  Proteasome inhibitor
0,117  0,014  Glycine receptor agonist
0,161  0,060  Thiol protease inhibitor
0,142  0,041  Sphingosine 1-phosphate receptor 4 antagonist
0,142  0,041  Contraceptive female
0,133  0,033  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,148  0,049  Antihemorrhagic
0,156  0,057  Antianemic
0,122  0,023  Cell adhesion molecule inhibitor
0,214  0,116  Antituberculosic
0,226  0,128  Antimycobacterial
0,133  0,036  UDP-glucose 4-epimerase inhibitor
0,124  0,026  NADH dehydrogenase inhibitor
0,104  0,007  SULT2A1 substrate
0,131  0,035  Potassium channel (Ca-activated) activator
0,111  0,015  Postmenopausal disorders treatment
0,101  0,005  Fumarate hydratase inhibitor
0,144  0,049  Alkylator
0,138  0,043  Excitatory amino acid transporter EAAC1 inhibitor
0,141  0,047  Beta amyloid protein antagonist
0,172  0,079  Dual specificity phosphatase 3 inhibitor
0,121  0,028  Interleukin 12 antagonist
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,102  0,008  Exportin-1 inhibitor
0,154  0,060  CNS active muscle relaxant
0,152  0,059  Alkaline phosphatase inhibitor
0,123  0,031  Triose-phosphate isomerase inhibitor
0,118  0,026  Phosphofructokinase-1 inhibitor
0,216  0,124  Gastrin inhibitor
0,150  0,059  Antifungal (Cryptococcus)
0,156  0,065  CF transmembrane conductance regulator agonist
0,103  0,012  Antimycoplasmal
0,096  0,005  Prostaglandin agonist
0,119  0,029  Antidote, mercury
0,104  0,015  Alpha tubulin antagonist
0,155  0,066  Antineoplastic (carcinoma)
0,130  0,041  AMP-activated protein kinase stimulant
0,115  0,026  Glutamate release inhibitor
0,167  0,078  3C-like protease (Human coronavirus) inhibitor
0,113  0,025  ATPase (Vacuolar H+) inhibitor
0,189  0,102  ErbB-1 antagonist
0,118  0,031  Topoisomerase II alpha inhibitor
0,101  0,015  Antitreponemal
0,193  0,106  Aryl hydrocarbon receptor agonist
0,105  0,021  Beta tubulin antagonist
0,150  0,066  Cell wall synthesis inhibitor
0,144  0,060  Farnesoid X receptor antagonist
0,125  0,042  Anticataract
0,092  0,010  Aconitate hydratase inhibitor
0,202  0,119  Antiprotozoal (Trypanosoma)
0,159  0,077  Interleukin 6 antagonist
0,133  0,051  DNA repair enzyme inhibitor
0,121  0,039  GST T1-1 substrate
0,091  0,009  Heme oxygenase stimulant
0,199  0,118  Antiviral (West Nile virus)
0,162  0,082  Dual specificity phosphatase inhibitor
0,144  0,064  Neurotrophic factor
0,134  0,054  Growth stimulant
0,104  0,025  D-Ala-D-Ala ligase inhibitor
0,084  0,006  Adenylate cyclase 1 inhibitor
0,170  0,094  Septic shock treatment
0,112  0,037  ABCA1 expression enhancer
0,126  0,050  Ferrochelatase inhibitor
0,083  0,007  Retinoid X receptor agonist
0,143  0,068  Cytokine production inhibitor
0,178  0,103  Histone acetyltransferase inhibitor
0,101  0,027  Peroxisome proliferator-activated receptor gamma agonist
0,260  0,187  DNA polymerase beta inhibitor
0,082  0,009  Squalene epoxidase inhibitor
0,111  0,039  Arylamine N-Acetyltransferase substrate
0,113  0,040  Alcohol dehydrogenase inhibitor
0,091  0,019  Human rhinovirus A protease inhibitor
0,079  0,007  Factor III inhibitor
0,086  0,015  Phosphorylase inhibitor
0,081  0,013  Postcoital contraceptive
0,256  0,188  DNA directed DNA polymerase inhibitor
0,118  0,050  Multidrug resistance-associated protein 1 inhibitor
0,150  0,082  Thrombolytic
0,079  0,012  Estrogen receptor alpha agonist
0,071  0,004  Kainate receptor agonist
0,099  0,033  Cathepsin G inhibitor
0,077  0,011  Ryanodine receptor antagonist
0,072  0,006  Farnesoid X receptor agonist
0,082  0,017  Peroxisome proliferator-activated receptor alpha agonist
0,087  0,022  Purinergic P2X1 antagonist
0,078  0,013  Potassium channel Kv1.3 blocker
0,199  0,134  Antineoplastic (bladder cancer)
0,195  0,130  Huntington's disease treatment
0,084  0,020  Antiviral (Parainfluenza)
0,144  0,080  Antidiarrheal
0,080  0,017  Transcription factor RelA inhibitor
0,135  0,072  Bone formation stimulant
0,080  0,017  Botulinum neurotoxin type A inhibitor
0,073  0,012  Leukotriene C antagonist
0,070  0,009  Retinoid X alpha receptor agonist
0,084  0,023  Antidote, heavy metal
0,069  0,007  Prostaglandin EP3 antagonist
0,068  0,006  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,103  0,042  Bile acid receptor antagonist
0,075  0,015  Estrogen receptor beta agonist
0,099  0,039  Metalloproteinase-2 inhibitor
0,096  0,037  3C-Like protease (SARS coronavirus) inhibitor
0,074  0,015  Thromboxane synthase inhibitor
0,140  0,081  Neuropeptide Y1 antagonist
0,218  0,160  Interleukin 2 agonist
0,091  0,033  Lipase inhibitor
0,113  0,055  HDL-cholesterol increasing
0,087  0,029  MAP kinase kinase 7 inhibitor
0,093  0,035  Glutamate dehydrogenase inhibitor
0,071  0,013  Pregnane X receptor antagonist
0,083  0,025  CDC25B inhibitor
0,063  0,006  Sodium-dependent vitamin C transporter 2 inhibitor
0,103  0,046  Phosphodiesterase 6D inhibitor
0,122  0,065  Topoisomerase II inhibitor
0,105  0,049  Lanosterol 14 alpha demethylase inhibitor
0,108  0,053  Antifungal (Aspergillus)
0,079  0,023  Nitric oxide donor
0,068  0,013  Heparanase inhibitor
0,087  0,033  MAP3K7 inhibitor
0,067  0,014  Glucose-6-phosphate isomerase inhibitor
0,059  0,006  Retinoid X receptor antagonist
0,084  0,032  Elastase 1 inhibitor
0,117  0,065  Transcription factor STAT6 inhibitor
0,079  0,027  Biliverdin reductase inhibitor
0,068  0,016  CD45 antagonist
0,084  0,035  GABA B receptor agonist
0,093  0,044  Myeloperoxidase inhibitor
0,189  0,140  Streptokinase A inhibitor
0,100  0,052  Antifungal (Candida)
0,135  0,087  Cytidine deaminase inhibitor
0,074  0,026  Transcription factor AP-1 inhibitor
0,084  0,038  Antidote, organophosphates
0,075  0,029  Neuraminidase inhibitor
0,134  0,088  Pregnane X receptor agonist
0,173  0,127  5 Hydroxytryptamine 3E antagonist
0,052  0,008  Catechol O-methyltransferase inhibitor
0,056  0,014  Dopamine D5 agonist
0,062  0,021  Anesthetic inhalation
0,075  0,034  Glutamate (mGluR7) antagonist
0,053  0,012  Retinoic acid alpha receptor agonist
0,048  0,008  Retinoid X alpha receptor antagonist
0,067  0,028  Thromboxane antagonist
0,092  0,053  Antineoplastic alkaloid
0,099  0,059  Electrolyte absorption antagonist
0,044  0,005  Prostaglandin F2 alpha agonist
0,134  0,095  Acute respiratory distress syndrome (ARDS) treatment
0,064  0,025  Thromboxane A2 antagonist
0,081  0,043  Histone deacetylase SIRT1 stimulant
0,081  0,043  Histone deacetylase stimulant
0,097  0,059  Antineoplastic, alkylator
0,113  0,075  Antineoplastic antimetabolite
0,083  0,044  Antibiotic
0,052  0,015  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,073  0,036  Hyperparathyroidism treatment
0,121  0,085  Antiprotozoal (Trichomonas)
0,050  0,014  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,043  0,007  Prostaglandin E2 agonist
0,048  0,012  Leukotriene C4 antagonist
0,072  0,036  Glutamate (mGluR6) antagonist
0,071  0,036  MDM2 inhibitor
0,067  0,032  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,070  0,035  Neuraminidase (influenza) inhibitor
0,056  0,021  Dopamine beta hydroxylase inhibitor
0,076  0,041  Peroxisome proliferator-activated receptor gamma antagonist
0,089  0,055  NMDA receptor antagonist
0,079  0,045  Metalloproteinase-9 inhibitor
0,043  0,010  Leukotriene B4 receptor 1 antagonist
0,064  0,031  Beta 1 adrenoreceptor antagonist
0,064  0,031  Carbonic anhydrase XII inhibitor
0,052  0,019  Guanylate cyclase inhibitor
0,068  0,036  Carbamoyl phosphate synthetase inhibitor
0,058  0,026  Glycine transporter 2 inhibitor
0,062  0,030  Matrix metalloproteinase 1 inhibitor
0,070  0,038  Beta adrenoreceptor antagonist
0,086  0,053  Antineoplastic antibiotic
0,040  0,008  Prostaglandin EP2 agonist
0,036  0,005  ICAM 1 antagonist
0,087  0,056  Transcription factor NF kappa B stimulant
0,040  0,010  NMDA 2D receptor antagonist
0,038  0,007  Retinoic acid receptor agonist
0,038  0,009  LFA antagonist
0,046  0,017  Nicotinic acid receptor agonist
0,090  0,062  Paget's disease treatment
0,076  0,048  CDC25A inhibitor
0,134  0,105  Aldose reductase substrate
0,071  0,043  Potassium channel large-conductance Ca-activated activator
0,041  0,013  HMG CoA reductase inhibitor
0,118  0,091  Antineoplastic (uterine cancer)
0,040  0,014  GABA transporter 3 inhibitor
0,035  0,010  NMDA receptor glycine site antagonist
0,064  0,039  Caspase 9 inhibitor
0,039  0,014  ATP citrate lysase inhibitor
0,043  0,018  Glutamate (mGluR8) agonist
0,083  0,058  Inducible nitric-oxide synthase inhibitor
0,043  0,020  Cholesterol absorption inhibitor
0,036  0,012  Prostaglandin EP4 antagonist
0,052  0,030  Plasminogen activator inhibitor antagonist
0,042  0,020  Inosine monophosphate dehydrogenase inhibitor
0,103  0,082  Antiviral (Coronavirus)
0,103  0,082  Antiviral (SARS coronavirus)
0,128  0,107  Raynaud's phenomenon treatment
0,028  0,007  Retinoic acid alpha receptor antagonist
0,029  0,008  Inosine monophosphate dehydrogenase 2 inhibitor
0,125  0,104  Hemostatic
0,091  0,071  Aminopeptidase B inhibitor
0,105  0,085  Interleukin 8 antagonist
0,063  0,044  Carbonic anhydrase inhibitor
0,036  0,018  Calcium-independent phospholipase A2 inhibitor
0,060  0,042  Aromatase inhibitor
0,070  0,053  Aminopeptidase I inhibitor
0,106  0,089  Shock treatment
0,055  0,038  Acyl-CoA dehydrogenase inhibitor
0,035  0,018  Estrogen-related receptor beta antagonist
0,063  0,047  Selectin antagonist
0,064  0,048  Uterine relaxant
0,054  0,037  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,055  0,039  Carbonic anhydrase IX inhibitor
0,061  0,045  Prostaglandin F2 alpha antagonist
0,138  0,122  Wound healing agent
0,041  0,025  GABA uptake inhibitor
0,025  0,010  Retinoic acid gamma receptor agonist
0,029  0,014  Nicotinic acid receptor 2 antagonist
0,092  0,077  Urease inhibitor
0,023  0,009  Retinoic acid receptor antagonist
0,064  0,049  Matrix metalloproteinase inhibitor
0,040  0,026  Membrane dipeptidase inhibitor
0,140  0,126  Psychostimulant
0,089  0,075  Protease inhibitor
0,091  0,078  NAT2 substrate
0,035  0,022  RNA-directed RNA polymerase inhibitor
0,025  0,012  Isoleucine-tRNA ligase inhibitor
0,023  0,010  Retinoid X beta receptor antagonist
0,063  0,051  Sphingosine 1-phosphate receptor 4 agonist
0,021  0,009  Estrogen-related receptor gamma agonist
0,106  0,095  Acetylcholinesterase inhibitor
0,033  0,021  Glutamate (mGluR3) agonist
0,027  0,016  Thyroid hormone agonist
0,033  0,022  Estrogen-related receptor alpha antagonist
0,053  0,042  Dihydroorotate oxidase inhibitor
0,067  0,056  Calcium channel L-type blocker
0,078  0,067  Antiviral (Trachoma)
0,076  0,065  Opioid kappa receptor antagonist
0,023  0,012  GABA transporter inhibitor
0,027  0,016  Methionyl aminopeptidase 2 inhibitor
0,032  0,023  Methionyl aminopeptidase 1 inhibitor
0,018  0,010  Vesicular glutamate transport inhibitor
0,202  0,193  Antiprotozoal (Plasmodium)
0,037  0,029  Integrin alpha1beta1 antagonist
0,038  0,030  Dihydropteroate synthase inhibitor
0,017  0,009  Thromboxane A2 agonist
0,119  0,112  Antiviral (Herpes)
0,014  0,007  Integrin beta2 antagonist
0,021  0,015  Neuraminidase (Influenza B) inhibitor
0,191  0,185  CYP3A4 inhibitor
0,017  0,011  Vitamin D receptor agonist
0,022  0,016  Leukotriene B4 receptor 2 antagonist
0,087  0,081  Chronic obstructive bronchitis treatment
0,029  0,024  Prostaglandin D2 agonist
0,127  0,122  Myocardial ischemia treatment
0,020  0,014  Retinoic acid beta receptor agonist
0,024  0,020  Leukotriene D4 antagonist
0,021  0,016  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,013  0,009  Integrin alphaLbeta2 antagonist
0,077  0,073  Opioid antagonist
0,046  0,042  Beta 2 adrenoreceptor antagonist
0,016  0,012  Carbonic anhydrase VIII inhibitor
0,016  0,012  Carbonic anhydrase X inhibitor
0,046  0,042  Antiviral (Herpesvirus 3, Human)
0,018  0,015  Antibiotic Anthracycline-like
0,024  0,021  Kynurenine 3 monooxygenase inhibitor
0,026  0,023  Retinoid X gamma receptor antagonist
0,054  0,052  Lipocortins synthesis agonist
0,052  0,050  Adenine nucleotide translocase inhibitor
0,049  0,047  Alpha-mannosidase inhibitor
0,024  0,023  Urotensin II agonist
0,010  0,009  Calcineurin inhibitor
0,014  0,013  Prostacyclin agonist
0,026  0,026  Estrogen-related receptor gamma antagonist
0,133  0,133  Diabetic nephropathy treatment

